61 phenotypes from 3 alleles in 5 genetic backgrounds

Allelic Composition Genetic Background	Annotated Term	Reference
Sptbem1(IMPC)J/Sptb+ C57BL/6NJ-Sptbem1(IMPC)J/Mmjax	decreased exploration in new environment	J:211773
	decreased mean corpuscular hemoglobin	J:211773
	decreased mean corpuscular volume	J:211773
	increased erythrocyte cell number	J:211773
Sptbem1(IMPC)J/Sptbem1(IMPC)J C57BL/6NJ-Sptbem1(IMPC)J/Mmjax	embryonic lethality prior to organogenesis	J:211773
	preweaning lethality, complete penetrance	J:211773
Sptbja/Sptb+ 129/Sv-Sptbja	anemia	J:5985
	increased erythrocyte protoporphyrin level	J:5985
Sptbja/Sptb+ (WB.129-Sptbja/J x B6.129-Sptbja/J)F1	increased erythrocyte clearance	J:44313
	increased erythrocyte osmotic fragility	J:44313
Sptbja/Sptb+ involves: 129/Sv * C57BL/6J * WB/Re	increased erythrocyte protoporphyrin level	J:5985
Sptbja/Sptbja 129/Sv-Sptbja	abnormal reticulocyte morphology	J:7501
	anisocytosis	J:305
	enlarged heart	J:305
	enlarged liver	J:305
	enlarged spleen	J:305
	hemolytic anemia	J:305
	jaundice	J:305
	multifocal hepatic necrosis	J:305
	neonatal lethality, incomplete penetrance	J:7501
	poikilocytosis	J:305
	prenatal lethality, incomplete penetrance	J:305
	reticulocytosis	J:305
Sptbja/Sptbja (WB.129-Sptbja/J x B6.129-Sptbja/J)F1	abnormal cardiac thrombosis	J:44313, J:62355
	abnormal erythrocyte morphology	J:62355
	abnormal erythrocyte osmotic lysis	J:162532
	abnormal erythrocyte physiology	J:162532
	abnormal myocardium layer morphology	J:44313
	anisopoikilocytosis	J:162532
	brain lesion	J:44313
	cardiac hypertrophy	J:162532
	cerebral infarct	J:44313
	decreased body size	J:162532
	decreased brain size	J:44313
	decreased cellular hemoglobin content	J:44313
	decreased circulating glucose level	J:44313
	decreased erythrocyte cell number	J:44313
	decreased hematocrit	J:44313, J:162532
	decreased hemoglobin content	J:44313, J:162532
	decreased total body fat amount	J:44313
	enlarged heart	J:44313
	enlarged liver	J:44313, J:162532
	enlarged spleen	J:44313, J:162532
	extramedullary hematopoiesis	J:162532
	glomerulonephritis	J:44313
	hemolysis	J:162532
	hemolytic anemia	J:162532
	hydronephrosis	J:44313
	increased blood urea nitrogen level	J:44313
	increased circulating bilirubin level	J:44313, J:162532
	increased circulating iron level	J:44313
	increased erythrocyte clearance	J:162532
	increased kidney iron level	J:44313
	increased nucleated erythrocyte cell number	J:162532
	increased spleen red pulp amount	J:44313
	infertility	J:162532
	jaundice	J:162532
	low mean erythrocyte cell number	J:162532
	microcytosis	J:62355
	neonatal lethality, incomplete penetrance	J:162532
	poikilocytosis	J:162532
	postnatal lethality, incomplete penetrance	J:44313, J:162532
	premature death	J:44313
	renal tubular necrosis	J:44313
	reticulocytosis	J:44313, J:162532
	schistocytosis	J:162532
	tubular nephritis	J:44313
	urolithiasis	J:44313
Sptbja/Sptbja involves: 129/Sv * C57BL/6J * WB/Re	increased erythrocyte protoporphyrin level	J:5985
Sptbm1Jus/Sptbm1Jus involves: 129S6/SvEvTac * C57BL/6	abnormal erythrocyte morphology	J:159750
	acanthocytosis	J:159750
	anemia	J:159750
	enlarged heart	J:159750
	enlarged kidney	J:159750
	enlarged liver	J:159750
	enlarged spleen	J:159750
	hemolysis	J:159750
	spherocytosis	J:159750